Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AT-527 + Daclatasvir in Chronic HCV Infection
NCT04019717Phase 2Completed
- Sponsor
- Atea Pharmaceuticals
- Start
- Jun 2019
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of bemnifosbuvir in hepatitis C (HCV), sponsored by Atea Pharmaceuticals. Started Jun 2019; status: completed.
02
Drugs
bemnifosbuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT04019717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04019717.